ELARIS is on a mission to help people live healthier, longer lives by fighting infectious diseases that threaten healthy aging. Our lead program is a highly differentiated vaccine against C. difficile — a severe diarrheal, hospital-acquired infection that hits elderly populations the hardest.
| Employees | 5 (3 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular ELARIS employee's phone or email?
Jason Golan is the CEO and Co-Founder of ELARIS.
3 people are employed at ELARIS.